03 April 2020
: Case report
Disseminated Cutaneous Tophi in a Patient with Chronic Tophaceous Gout and Renal Impairment: A Case Report of a Rare Manifestation of Gout
Rare disease
Faisal Parlindungan1DEF*, Bambang Setiyohadi1EF, Riesye Arisanti2DDOI: 10.12659/AJCR.919349
Am J Case Rep 2020; 21:e919349
Abstract
BACKGROUND: Gout is a metabolic disease characterized by deposition of monosodium urate (MSU) crystals called tophi. The typical location of tophi is in the joint and will chronically damage the joint. However, there is a rare atypical dermatologic manifestation of tophi that occur extensively in the skin.
CASE REPORT: A 46-year-old male presented with acute pain in multiple joints. He had a history of gouty arthritis with recurrence attacks, in the past 2 years ago. Over time, he had gradual eruption of multiple tophi and multiple yellowish nodules under his skin which sometimes would ulcerate. Laboratory value showed creatinine 2.3 mg/dL and uric acid 11.5 mg/dL. Ultrasound of the kidney showed nephrocalcinosis appearance. Urate crystal was identified in skin biopsy of the nodules. We diagnosed the patient with chronic tophaceous gout with extensive cutaneous involvement. Given the renal impairment, we gave methylprednisolone 3 doses of 8 mg for 5 days then tapered off, colchicine 0.5 mg every other day and allopurinol 1 dose of 100 mg. The patient had dramatic improvement of his pain and is now being followed up regularly.
CONCLUSIONS: We describe a rare and severe extensive cutaneous manifestation in a chronic tophaceous gout patient.
Keywords: gout, Renal Insufficiency, Chronic, Uric Acid, Allopurinol, Arthritis, Gouty, Colchicine, Glucocorticoids, Gout Suppressants, Methylprednisolone, renal insufficiency, Skin Diseases
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.949194
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.948731
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947386
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.948268
Most Viewed Current Articles
21 Jun 2024 : Case report
101,937
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
54,506
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
38,182
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
07 Jul 2023 : Case report
25,994
DOI :10.12659/AJCR.940200
Am J Case Rep 2023; 24:e940200